Apply for CMS 2A2 20 001
- The Department of Health and Human Services, Centers for Medicare Medicaid Services in the health sector is offering a public funding opportunity titled "Maternal Opioid Misuse (MOM) Model" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.687.
- This funding opportunity was created on Feb 08, 2019.
- Applicants must submit their applications by May 06, 2019 The application is due 5/06/2019 at 300 p.m. EST..
- Each selected applicant is eligible to receive up to $5,380,000.00 in funding.
- The number of recipients for this funding is limited to 12 candidate(s).
- Eligible applicants include: State governments.
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Ecosystem Studies Unit, Pacific Northwest CESU
Previous opportunity: Implementation of Integrated HIV/AIDS Prevention, Care, and Treatment Programs in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.Apply for CMS 2A2 20 001
Applicants also applied for:
Applicants who have applied for this opportunity (CMS 2A2 20 001) also looked into and applied for these:
|Funding Number||Funding Title|
|CMS 2B2 20 001||Integrated Care for Kids (InCK)|
|HRSA 19 110||Service Area Competition-Additional Area (SAC-AA) — Pago Pago, American Samoa|
|CDC RFA EH19 1901||State-Based Public Health Laboratory Biomonitoring Programs|
|CDC RFA PS19 1908||Systems-level Approach to Improving Health Outcomes for HIV-positive State Prison Inmates Released to the Community|
|72011519RFA00003||USAID/Kyrgyz Republic Tuberculosis (TB) Control Program|
|AH TP1 19 001||Announcement of Availability of Funds for Replication of Programs Proven Effective through Rigorous Evaluation to Reduce Teenage Pregnancy, Behavioral Risk Factors Underlying Teenage Pregnancy, or Other Associated Risk Factors (Tier 1) Phase I|
|MP CPI 19 001||OMH Hepatitis B Demonstration Grant Program|
|CDC RFA CK19 1902||Performing Regulatory-Required Medical Examinations for U.S. Bound Populations by US Screening Physicians|
|DOS MSU PFSGP FY19||PEPFAR Small Grants Program 2019-2020|
|DOS MSU PFSGPCB FY19||PEPFAR Small Grants Program 2019-2020 Capacity Building|
|CDC RFA PS19 1907||STD Surveillance Network (SSuN)|
|CDC RFA DD19 1902||Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults|
|RFA NS 19 012||Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed)|
|CDC RFA DP19 1905||The CDC Cancer Genomics Program: Translating Research into Public Health Practice|
|SM 19 007||FY 2019 Linking Actions for Unmet Needs in Children’s Health Grant Program|
|CDC RFA DP19 1906||Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients|
|HRSA 19 018||Small Health Care Provider Quality Improvement Program|
|TI 19 008||Minority Aids Initiative: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at High Risk for HIV/AIDS|
|RFA AI 19 010||Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed)|
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CMS 2A2 20 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.